Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage
Patients with intracerebral hemorrhage (ICH) are at increased risk for major ischemic cardiovascular and cerebrovascular events. However, the use of preventative antithrombotic therapy can increase the risk of ICH recurrence and worsen ICH-related outcomes. Colchicine, an anti-inflammatory agent, ha...
Main Authors: | Cassandra M. Wilkinson, Aristeidis H. Katsanos, Noam H. Sander, Tiffany F. C. Kung, Frederick Colbourne, Ashkan Shoamanesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578626/?tool=EBI |
Similar Items
-
Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage.
by: Cassandra M Wilkinson, et al.
Published: (2022-01-01) -
Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.
by: Cassandra M Wilkinson, et al.
Published: (2019-01-01) -
Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat.
by: Lane Liddle, et al.
Published: (2019-01-01) -
A systematic review and meta-analysis on the efficacy of glibenclamide in animal models of intracerebral hemorrhage.
by: Tiffany F C Kung, et al.
Published: (2023-01-01) -
A systematic review and meta-analysis on the efficacy of glibenclamide in animal models of intracerebral hemorrhage
by: Tiffany F. C. Kung, et al.
Published: (2023-01-01)